期刊文献+

人类尾加压素Ⅱ在胎儿肺脏中分布的免疫组化研究 被引量:1

Immunohistochemical study on distribution of human urotensin Ⅱ in fetal lung tissue
下载PDF
导出
摘要 目的为探索胎儿时期肺循环的调节机制,了解血管活性肽-人类尾加压素Ⅱ(hUⅡ)在胎儿肺脏中的表达情况。方法随机收集10例不同胎龄人工流产胎儿肺组织,常规福尔马林固定,石蜡包埋切片后用免疫组织化学技术,观察hUⅡ在肺组织中的表达。结果在胎龄12~15周的胎儿肺脏中,血管数目很少,免疫组化显示在血管组织中未见到免疫活性hUⅡ阳性表达,免疫活性hUⅡ在肺内支气管和细支气管的上皮中分布广泛;在胎龄18~25周的肺脏中,免疫活性hUⅡ表达显著减少,只在大型肺血管内皮和肺内支气管的上皮中表达。结论hUⅡ可能在人类肺脏的发生、分化过程中起一定的作用。 Objective Fetal pulmonary circulation was characterized by high resistance and low flow rate. But its mechanism was not fully understood. In order to explore the regulatory mechanism of pulmonary circulation, the distribution of immunoreactive human urotensin Ⅱ in the lung in different gestation periods was investigated. Methods The lung specimens from abortive fetuses(n= 10)in different gestational periods were randomly collected and fixed in formalin and embedded with paraffin. The expression level and distribution of human adrenomedullin urotensin Ⅱwere evaluated with immunohistochemistry technique. Results Urotensin Ⅱ was widely distributed in the epithelial cells of bronchi,with the peak level in the specimens from 12 to 15 week gestational period. While U Ⅱ immunostaining intensity was significantly decreased in the bronchial epithelial cells among those gestational period from 18 to 25 weeks. Only in relatively larger bronchi and blood vessels,could a little positive staining in the epithelial and endothelial cells could be observed. Conclusions Human urotensin Ⅱ existed in fetal lung and might play a role in ontogenesis.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2005年第3期140-142,共3页 Journal of Clinical Pediatrics
基金 国家杰出青年科学基金(30425010)国家重点基础研究发展规划(G2000056905)资助
关键词 人类尾加压素 胎儿 免疫组化 human urotensin fetus immunohistochemistry
  • 相关文献

参考文献6

  • 1Yan RY.Foundamental of perinatology.People's Health Press, 1987.145.
  • 2Maclean MR, Alexander D, Atirrat A, et al.Contractile responses to human urotensin -Ⅱ in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat.Br J Pharmacol, 2000, 130( 2): 201- 204.
  • 3Stirrat A, Gallagher M, Douglas SA, et al.Potent vasodilator responses to human urotensin -Ⅱ in human pulmonary and abdominal resistance arteries.Am J Physiol Heart Cire Physiol, 2001, 280( 2): H925- 928.
  • 4田宏,杜军保,张宝红,赵卫红,唐朝枢.尾加压素对常氧及低氧大鼠肺动脉平滑肌细胞周期的影响[J].中国应用生理学杂志,2003,19(1):1-3. 被引量:3
  • 5Hay DW, Luttmann MA, Douglas SA.Human urotensin-Ⅱ is a potent spasmogen of primate airway smooth muscle.Br J Pharmacol, 2000, 131( 1): 10- 12.
  • 6Coulouarn Y, Lihrmann I, Jegou S, et al.Cloning of the cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord.Proc Natl Acad Sci USA, 1998, 95(26): 15803- 15808.

二级参考文献2

共引文献2

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部